Published in JAMA on November 24, 1989
The logic in ecological: II. The logic of design. Am J Public Health (1994) 5.55
Choosing a future for epidemiology: I. Eras and paradigms. Am J Public Health (1996) 5.25
Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A (1997) 4.38
Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA (2013) 4.08
Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol (2005) 2.62
Neural tube defects and folate: case far from closed. Nat Rev Neurosci (2006) 2.30
Folic acid supplements in pregnancy and severe language delay in children. JAMA (2011) 2.18
Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol (2010) 2.12
Folic acid fortification of grain: an economic analysis. Am J Public Health (1995) 2.00
Folic acid fortification: what does it mean for patients and physicians? CMAJ (1998) 1.95
"Folate up" for healthy babies. CMAJ (1994) 1.71
Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol (2008) 1.69
Public health 101 for informaticians. J Am Med Inform Assoc (2001) 1.51
The Human Genome Project and eugenic concerns. Am J Hum Genet (1994) 1.50
Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci U S A (1996) 1.38
Understanding nutritional epidemiology and its role in policy. Adv Nutr (2015) 1.37
Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification. Am J Public Health (2006) 1.17
Folic acid in early pregnancy: a public health success story. FASEB J (2010) 1.16
Understanding and determining the etiology of autism. Cell Mol Neurobiol (2009) 1.15
Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health. Am J Public Health (2005) 1.13
Autoantibodies to folate receptor during pregnancy and neural tube defect risk. J Reprod Immunol (2008) 1.03
Folic acid and neural tube defect: can't we come to closure? Am J Public Health (1992) 1.01
Folate status of reproductive age women and neural tube defect risk: the effect of long-term folic acid supplementation at doses of 140 µg and 400 µg per day. Nutrients (2011) 0.98
Ophthalmologic complications of meningomyelocele: a longitudinal study. Trans Am Ophthalmol Soc (1990) 0.97
Who should take vitamin supplements? BMJ (1990) 0.96
Neural tube defects, folic acid and methylation. Int J Environ Res Public Health (2013) 0.95
How do we get enough folic acid to prevent some neural tube defects? Am J Public Health (1994) 0.94
Awareness of spina bifida and periconceptional use of folic acid among pregnant women in a developing economy. Childs Nerv Syst (2012) 0.93
Folic Acid and Epilepsy. Epilepsy Curr (2002) 0.92
Whole genomewide linkage screen for neural tube defects reveals regions of interest on chromosomes 7 and 10. J Med Genet (2005) 0.92
Folic acid and human reproduction-ten important issues for clinicians. J Exp Clin Assist Reprod (2011) 0.90
Trends in folic Acid awareness and behavior in the United States: the Gallup Organization for the March of Dimes Foundation surveys, 1995-2005. Matern Child Health J (2006) 0.90
Periconceptional nutrient intakes and risks of neural tube defects in California. Birth Defects Res A Clin Mol Teratol (2010) 0.89
Cytogenetic damage induced by folate deficiency in mice is enhanced by caffeine. Proc Natl Acad Sci U S A (1990) 0.89
Long-term effect of low-dose folic acid intake: potential effect of mandatory fortification on the prevention of neural tube defects. Am J Clin Nutr (2011) 0.87
Invited commentary: Preventing neural tube defects and more via food fortification? Am J Epidemiol (2008) 0.87
Estimate of the potential impact of folic acid fortification of corn masa flour on the prevention of neural tube defects. Birth Defects Res A Clin Mol Teratol (2013) 0.86
Periconceptional vitamin supplementation and neural tube defects; evidence from a case-control study in Western Australia and a review of recent publications. J Epidemiol Community Health (1992) 0.86
Achieving a public health recommendation for preventing neural tube defects with folic acid. Am J Public Health (1999) 0.85
The effect of folic acid, protein energy and multiple micronutrient supplements in pregnancy on stillbirths. BMC Public Health (2011) 0.84
Use of folic acid supplements in early pregnancy in relation to maternal plasma levels in week 18 of pregnancy. Mol Nutr Food Res (2012) 0.83
Prenatal vitamin intake during pregnancy and offspring obesity. Int J Obes (Lond) (2013) 0.83
Neural tube defects--why are rates high among populations of Mexican descent? Environ Health Perspect (1995) 0.82
Regulation of folate receptor 1 gene expression in the visceral endoderm. Birth Defects Res A Clin Mol Teratol (2009) 0.81
Low maternal retinol as a risk factor for schizophrenia in adult offspring. Schizophr Res (2012) 0.81
Mutation at the folate receptor 4 locus modulates gene expression profiles in the mouse uterus in response to periconceptional folate supplementation. Biochim Biophys Acta (2013) 0.80
The fetal origins of the metabolic syndrome: can we intervene? J Pregnancy (2012) 0.79
Prevalence and predictors of unintended pregnancy among women: an analysis of the Canadian Maternity Experiences Survey. BMC Pregnancy Childbirth (2015) 0.78
High-density single nucleotide polymorphism screen in a large multiplex neural tube defect family refines linkage to loci at 7p21.1-pter and 2q33.1-q35. Birth Defects Res A Clin Mol Teratol (2006) 0.78
Issues in the prevention of spina bifida. J R Soc Med (1996) 0.78
Monitoring maternal Beta carotene and retinol consumption may decrease the incidence of neurodevelopmental disorders in offspring. Clin Med Insights Reprod Health (2011) 0.77
Effectiveness of Folic Acid Fortified Flour for Prevention of Neural Tube Defects in a High Risk Region. Nutrients (2016) 0.76
Patterns of folic acid use in pregnant Saudi women and prevalence of neural tube defects - Results from a nested case-control study. Prev Med Rep (2015) 0.76
Health effects of oxygenated fuels. Environ Health Perspect (1993) 0.76
Folic acid prescription in pregnancy. Ulster Med J (1995) 0.75
Clinical spectrum of neural tube defects with special reference to karyotyping study. J Pediatr Neurosci (2012) 0.75
Congenital Malformations and Consequential Epidemiology. Curr Epidemiol Rep (2015) 0.75
Maternal Folic Acid Supplementation during Pregnancy and Childhood Allergic Disease Outcomes: A Question of Timing? Nutrients (2017) 0.75
Correlation of Oxidative Damage with Pro-Inflammatory Markers (IL-6, TNF-α) in Meningocele. J Clin Diagn Res (2016) 0.75
Fetal drug therapy. West J Med (1993) 0.75
Detecting gene-environment interactions in human birth defects: Study designs and statistical methods. Birth Defects Res A Clin Mol Teratol (2015) 0.75
Could folic acid influence growth cone motility during the development of neural connectivity? Neurogenesis (Austin) (2016) 0.75
More on folic acid and neural tube defects. Am J Public Health (1995) 0.75
The association of prenatal nutrition and educational services with low birth weight rates in a Florida program. Public Health Rep (1991) 0.75
Folic acid and prevention of neural tube defects. CMAJ (1992) 0.75
Technology and pediatric neurosurgery: our industrial revolution? Childs Nerv Syst (1995) 0.75
Iniencephaly: Case Report. J Pediatr Neurosci (2015) 0.75
Are epidemiological approaches suitable to study risk/preventive factors for human birth defects? Curr Epidemiol Rep (2015) 0.75
Vitamins during pregnancy and neural tube defects. JAMA (1990) 0.75
California's public health policy on preventing neural tube defects by folate supplementation. West J Med (1995) 0.75
Prevention of myelomeningocele: African perspectives. Childs Nerv Syst (2013) 0.75
Preconceptional folic acid supplementation in Japan. Congenit Anom (Kyoto) (2017) 0.75
No adjustments are needed for multiple comparisons. Epidemiology (1990) 23.80
Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ (1991) 17.91
Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol (1993) 7.73
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet (1995) 7.55
Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.40
Causes. Am J Epidemiol (1976) 5.78
Statins and the risk of dementia. Lancet (2000) 5.65
Histamine-2 receptor antagonists and gastric cancer. Epidemiology (1996) 5.43
Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ (2001) 5.40
Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA (1999) 5.37
Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med (1993) 5.19
A show of confidence. N Engl J Med (1978) 4.90
Antidepressants and suicide. BMJ (1995) 4.84
Concepts of interaction. Am J Epidemiol (1980) 4.80
Breast cancer (1) N Engl J Med (1992) 4.79
Cigarette smoking, relative weight, and menopause. Am J Epidemiol (1983) 4.46
Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy (1984) 4.39
Ethics of a prostate cancer screening trial. Lancet (1994) 4.21
A comparison of the risk of hypoglycemia between users of human and animal insulins. 1. Experience in the United Kingdom. Pharmacotherapy (1990) 3.98
HMG-CoA reductase inhibitors and the risk of fractures. JAMA (2000) 3.91
Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet (1998) 3.69
Epidemiology and the internet. Epidemiology (1997) 3.48
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet (2001) 3.48
Cigarette smoking and ulcerative colitis. N Engl J Med (1983) 3.47
Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet (2000) 3.35
A sobering start for the cluster busters' conference. Am J Epidemiol (1990) 3.33
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol (1990) 3.32
Addiction rare in patients treated with narcotics. N Engl J Med (1980) 3.20
Conflict of interest. The new McCarthyism in science. JAMA (1993) 3.02
Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99
Induction and latent periods. Am J Epidemiol (1981) 2.93
Comprehensive drug surveillance. JAMA (1970) 2.92
The estimation of synergy or antagonism. Am J Epidemiol (1976) 2.92
Drug surveillance utilizing nurse monitors. An epidemiological approach. Lancet (1966) 2.69
Replacement estrogens and endometrial cancer. N Engl J Med (1979) 2.65
Synergy and antagonism in cause-effect relationships. Am J Epidemiol (1974) 2.57
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
Coffee, caffeine, and cardiovascular disease in men. N Engl J Med (1990) 2.49
Science and policy making. Am J Public Health (1985) 2.45
Drugs--remarkably nontoxic. N Engl J Med (1974) 2.43
Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet (1998) 2.39
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Statin use and cancer risk in the General Practice Research Database. Br J Cancer (2004) 2.34
Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res (1999) 2.30
The discovery of drug-induced illness. N Engl J Med (1977) 2.29
Birth weight and cognitive function in young adult life: historical cohort study. BMJ (1997) 2.29
Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol (2001) 2.27
That confounded P-value. Epidemiology (1998) 2.26
Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. A controlled trial. Lancet (1965) 2.18
The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer (2000) 2.17
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol (1989) 2.12
Evaluation of four methods for determining energy intake in young and older women: comparison with doubly labeled water measurements of total energy expenditure. Am J Clin Nutr (1996) 2.11
Excess melanoma incidence in a cohort exposed to high levels of environmental selenium. Cancer Epidemiol Biomarkers Prev (1998) 2.10
Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring: a cohort study. Clin Exp Allergy (2014) 2.06
The incidence and severity of burn injuries following Project Burn Prevention. Am J Public Health (1982) 2.05
Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex (1998) 2.03
Spermicide use and Down's syndrome. Am J Public Health (1982) 2.00
Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1977) 2.00
Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol (2009) 1.99
Omeprazole, other antiulcer drugs and newly diagnosed gout. Br J Clin Pharmacol (1997) 1.99
Epidemiology of laryngeal cancer. Epidemiol Rev (1980) 1.90
Determinants of age at menarche as early life predictors of breast cancer risk. Int J Cancer (1996) 1.89
Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol (1978) 1.88
Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol (1979) 1.83
Antidepressant drugs and suicide. J Clin Psychopharmacol (1992) 1.80
Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med (1994) 1.79
The epidemiologist's lament. Am J Public Health (1981) 1.78
Utility of telephone company records for epidemiologic studies of cellular telephones. Epidemiology (1996) 1.77
Epidemiologic methods in clinical trials. Cancer (1977) 1.76
Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis (2000) 1.75
The epidemic of endometrial cancer: a commentary. Am J Public Health (1980) 1.74
Vaginal spermicides and congenital disorders. JAMA (1981) 1.74
Placebo mania. BMJ (1996) 1.72
Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol (1998) 1.66
Coffee and myocardial infarction. N Engl J Med (1973) 1.66
Fatal drug reactions among medical inpatients. JAMA (1971) 1.64
The demand for eating disorder care. An epidemiological study using the general practice research database. Br J Psychiatry (1996) 1.63
The risk of venous thromboembolism in users of postcoital contraceptive pills. Contraception (1999) 1.62
Pregnancies and terminations after 1995 warning about third-generation oral contraceptives. Lancet (1998) 1.61
Evaluation of drug efficacy by a preference technic. N Engl J Med (1966) 1.60
Haemophilus influenzae vaccine. Br J Gen Pract (1995) 1.59
Mortality in current and former users of clozapine. Epidemiology (1997) 1.58